| 1 |
Praharaj DL, Anand AC. Clinical Implications, Evaluation, and Management of Hyponatremia in Cirrhosis. J Clin Exp Hepatol 2022;12:575-94. [PMID: 35535075 DOI: 10.1016/j.jceh.2021.09.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 2 |
Lenci I, Milana M, Grassi G, Signorello A, Aglitti A, Baiocchi L. Natremia and liver transplantation: The right amount of salt for a good recipe. World J Hepatol 2020;12:919-30. [PMID: 33312419 DOI: 10.4254/wjh.v12.i11.919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 3 |
Alukal JJ, John S, Thuluvath PJ. Hyponatremia in Cirrhosis: An Update. Am J Gastroenterol 2020;115:1775-85. [PMID: 33156095 DOI: 10.14309/ajg.0000000000000786] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 4 |
Li M, Bi Z, Huang Z. Impact of Vaptans on Clinical Outcomes in Cirrhosis Patients: A Meta-Analysis of Randomized Controlled Trials. Front Pharmacol. 2019;10:1365. [PMID: 31824315 DOI: 10.3389/fphar.2019.01365] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 5 |
Piano S, Tonon M, Angeli P. Ascites, Hyponatremia, Spontaneous Bacterial Peritonitis, and Hepatorenal Syndrome. Evidence-based Gastroenterology and Hepatology 4e 2019. [DOI: 10.1002/9781119211419.ch43] [Reference Citation Analysis]
|
| 6 |
Jiménez JV, Carrillo-Pérez DL, Rosado-Canto R, García-Juárez I, Torre A, Kershenobich D, Carrillo-Maravilla E. Electrolyte and Acid-Base Disturbances in End-Stage Liver Disease: A Physiopathological Approach. Dig Dis Sci 2017;62:1855-71. [PMID: 28501971 DOI: 10.1007/s10620-017-4597-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 7 |
Cavaggioni G, Poli E, Ferri F, Parlati L, Monaco V, Melcore C, Lattanzi B, Merli M, Mennini G, Melandro F, Rossi M, Ginanni Corradini S. MELDNa score is associated with psychopathology and reduced quality of life in cirrhotic patients with a liver transplant perspective. Metab Brain Dis 2017;32:923-33. [DOI: 10.1007/s11011-017-9987-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 8 |
Bhat M, Rollet-Kurhajec KC, Bhat A, Farag A, Deschenes M, Wong P, Ghali P, Sebastiani G. Incidence and Predictors of Advanced Liver Fibrosis by a Validated Serum Biomarker in Liver Transplant Recipients. Can J Gastroenterol Hepatol 2017;2017:4381864. [PMID: 28409147 DOI: 10.1155/2017/4381864] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 9 |
Lizaola B, Bonder A, Tapper EB, Mendez-bocanegra A, Cardenas A. The Changing Role of Sodium Management in Cirrhosis. Curr Treat Options Gastro 2016;14:274-84. [DOI: 10.1007/s11938-016-0094-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 10 |
Sterns RH, Silver SM. Complications and management of hyponatremia: . Current Opinion in Nephrology and Hypertension 2016;25:114-9. [DOI: 10.1097/mnh.0000000000000200] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
|
